BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38904500)

  • 1. Effects of sex on clinical outcomes of hypertrophic cardiomyopathy in Singapore.
    Li TY; Yeo S; Ngiam NJ; Lee CH; Low TT; Lim YC; Evangelista LKM; Lee EC; Sari NY; Yeo TC; Yip JW; Poh KK; Kong WK; Lin W; Sia CH; Wong RC
    Ann Acad Med Singap; 2023 Jul; 52(7):348-355. PubMed ID: 38904500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.
    Fumagalli C; Maurizi N; Day SM; Ashley EA; Michels M; Colan SD; Jacoby D; Marchionni N; Vincent-Tompkins J; Ho CY; Olivotto I;
    JAMA Cardiol; 2020 Jan; 5(1):65-72. PubMed ID: 31693057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise echocardiography in asymptomatic HCM: exercise capacity, and not LV outflow tract gradient predicts long-term outcomes.
    Desai MY; Bhonsale A; Patel P; Naji P; Smedira NG; Thamilarasan M; Lytle BW; Lever HM
    JACC Cardiovasc Imaging; 2014 Jan; 7(1):26-36. PubMed ID: 24290569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E/e' ratio and outcome prediction in hypertrophic cardiomyopathy: the influence of outflow tract obstruction.
    Lu DY; Haileselassie B; Ventoulis I; Liu HY; Liang HY; Pozios I; Canepa M; Phillip S; Abraham MR; Abraham T
    Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):101-107. PubMed ID: 28977350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of mitral regurgitation in patients with hypertrophic cardiomyopathy using aortic and pulmonary flow data: impacts of left ventricular outflow tract obstruction and different left ventricular segmentation methods.
    Śpiewak M; Kłopotowski M; Gawor M; Kubik A; Kowalik E; Miłosz-Wieczorek B; Dąbrowski M; Werys K; Mazurkiewicz Ł; Kożuch K; Polańska-Skrzypczyk M; Petryka-Mazurkiewicz J; Klisiewicz A; Bilińska ZT; Grzybowski J; Witkowski A; Marczak M
    J Cardiovasc Magn Reson; 2017 Dec; 19(1):105. PubMed ID: 29268761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.
    Lu DY; Pozios I; Haileselassie B; Ventoulis I; Liu H; Sorensen LL; Canepa M; Phillip S; Abraham MR; Abraham TP
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of gender on heart failure presentation in non-obstructive hypertrophic cardiomyopathy.
    Jang JH; Shin SH; Beak YS; Ko KY; Kwon SW; Park SD; Woo SI; Kim DH; Kwan J
    Heart Vessels; 2020 Feb; 35(2):214-222. PubMed ID: 31482215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, Clinical Characteristics, and Long-term Outcome of the Dilated Phase of Hypertrophic Cardiomyopathy.
    Aizawa Y; Tanimoto Y; Hirata Y; Fujisawa T; Fukuoka R; Nakajima K; Katsumata Y; Nishiyama T; Kimura T; Yuasa S; Kohno T; Kohsaka S; Murata M; Maekawa Y; Furukawa Y; Takatsuki S; Fukuda K
    Keio J Med; 2019 Dec; 68(4):87-94. PubMed ID: 30606897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy.
    Olivotto I; Maron MS; Adabag AS; Casey SA; Vargiu D; Link MS; Udelson JE; Cecchi F; Maron BJ
    J Am Coll Cardiol; 2005 Aug; 46(3):480-7. PubMed ID: 16053962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of long-term outcomes in patients with hypertrophic cardiomyopathy undergoing cardiopulmonary stress testing and echocardiography.
    Masri A; Pierson LM; Smedira NG; Agarwal S; Lytle BW; Naji P; Thamilarasan M; Lever HM; Cho LS; Desai MY
    Am Heart J; 2015 May; 169(5):684-692.e1. PubMed ID: 25965716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical response to exercise in asymptomatic hypertrophic cardiomyopathy: a new description of outflow tract obstruction dynamics.
    Lafitte S; Reant P; Touche C; Pillois X; Dijos M; Arsac F; Peyrou J; Montaudon M; Ritter P; Roudaut R; Demaria A
    J Am Coll Cardiol; 2013 Aug; 62(9):842-50. PubMed ID: 23810875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of the systolic anterior motion of the mitral valve among patients without hypertrophic cardiomyopathy.
    Uematsu S; Takaghi A; Imamura Y; Ashihara K; Hagiwara N
    J Cardiol; 2017 Feb; 69(2):495-500. PubMed ID: 27241937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of peak provoked left ventricular outflow tract gradients on clinical outcomes in hypertrophic cardiomyopathy.
    Lu DY; Hailesealassie B; Ventoulis I; Liu H; Liang HY; Nowbar A; Pozios I; Canepa M; Cresswell K; Luo HC; Abraham MR; Abraham TP
    Int J Cardiol; 2017 Sep; 243():290-295. PubMed ID: 28747034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between left ventricular outflow tract obstruction and left ventricular shape in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
    Martin R; Lairez O; Boudou N; Méjean S; Lhermusier T; Dumonteil N; Berry M; Cognet T; Massabuau P; Elbaz M; Rousseau H; Galinier M; Carrié D
    Arch Cardiovasc Dis; 2013; 106(8-9):440-7. PubMed ID: 23906680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of exercise-induced mitral regurgitation on hypertrophic cardiomyopathy outcomes.
    Feneon D; Schnell F; Galli E; Bernard A; Mabo P; Daubert JC; Leclercq C; Carre F; Donal E
    Eur Heart J Cardiovasc Imaging; 2016 Oct; 17(10):1110-7. PubMed ID: 26476399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy.
    Eberly LA; Day SM; Ashley EA; Jacoby DL; Jefferies JL; Colan SD; Rossano JW; Semsarian C; Pereira AC; Olivotto I; Ingles J; Seidman CE; Channaoui N; Cirino AL; Han L; Ho CY; Lakdawala NK
    JAMA Cardiol; 2020 Jan; 5(1):83-91. PubMed ID: 31799990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
    Fananapazir L; Epstein ND; Curiel RV; Panza JA; Tripodi D; McAreavey D
    Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vector flow mapping in obstructive hypertrophic cardiomyopathy to assess the relationship of early systolic left ventricular flow and the mitral valve.
    Ro R; Halpern D; Sahn DJ; Homel P; Arabadjian M; Lopresto C; Sherrid MV
    J Am Coll Cardiol; 2014 Nov; 64(19):1984-95. PubMed ID: 25440093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long mitral valve leaflets determine left ventricular outflow tract obstruction during exercise in hypertrophic cardiomyopathy.
    Henein M; Arvidsson S; Pilebro B; Backman C; Mörner S; Lindqvist P
    Int J Cardiol; 2016 Jun; 212():47-53. PubMed ID: 27031819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of cardiac dysfunction coinciding with exertional breathlessness in hypertrophic cardiomyopathy.
    Maras D; Chung R; Duncan A; Li W; Thorp C; Mörner S; Lindqvist P; Henein MY
    Int J Cardiol; 2013 Dec; 170(2):233-8. PubMed ID: 24210420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.